Eco R1 Capital, LLC Tcr2 Therapeutics Inc. Transaction History

Eco R1 Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$6.01 - $16.01 $1.44 Million - $3.83 Million	-239,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.17 - $17.88 $2.91 Million - $4.28 Million	239,500 New	239,500 $3.42 Million
Q3 2019 Nov 14, 2019	SELL	$10.15 - $19.53 $163,557 - $314,706	-16,114 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.64 - $20.97 $219,794 - $337,910	16,114 New	16,114 $231,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.